Post-liver transplantation outcomes in acute-on-chronic liver failure: Impact of alcohol as a precipitant and etiology of chronic liver disease [0.03%]
急性重型肝炎导致的终末期肝病接受肝移植术后的预后及其影响因素分析
Victoria E Kusztos,Tiffany Wu,Blake Kassmeyer et al.
Victoria E Kusztos et al.
Background: Acute-on-chronic liver failure (ACLF) has been associated with excellent post- liver transplant (LT) outcomes at one year, however the impact of alcohol as ACLF precipitant, specifically alcohol-associated hep...
The impact of frailty on liver transplant candidacy - A survey study on current clinical practices in the United States [0.03%]
脆弱性对肝脏移植资格的影响——一项关于美国当前临床实践的调查研究
Avesh J Thuluvath,Adam Buckholz,Arpan Patel et al.
Avesh J Thuluvath et al.
Graft PD-L1 as a predictive marker for rejection in PD-1 inhibitor therapy for recurrent liver tumors post-transplant: A prospective pilot trial [0.03%]
程序性死亡配体1预测移植后复发性肝肿瘤PD-1抑制剂治疗排斥反应的临床研究：一项前瞻性队列研究
Yifeng He,Xiaowu Huang,Xiaoyong Huang et al.
Yifeng He et al.
The safety of immunotherapy in transplant patients remains unclear due to rejection risks. This study assessed the safety and efficacy of programmed death-1 (PD-1) inhibitors in post liver-transplantation patients with recurrent tumors, emp...
Potential missed opportunities to improve long-term liver allograft health [0.03%]
改善长期肝移植受者肝脏健康的潜在机会
Mohammad Amin Fallahzadeh,Geoffrey W McCaughan,Jacqueline G O&#x;Leary
Mohammad Amin Fallahzadeh
Long-term patient and allograft health after liver transplantation remain suboptimal because of alloimmune complications, malignancy, and consequences of the metabolic syndrome, often exacerbated by current standard of care immunosuppressio...
Disparities in access to early liver transplantation for alcohol-associated liver disease: More to do for patients in need [0.03%]
酒精相关性肝病患者早期进行肝脏移植的接受率差异问题仍然亟待解决
Kawthar A Mohamed,Nicholas Lim
Kawthar A Mohamed
Robert S Brown Jr,R Mark Ghobrial
Robert S Brown Jr
Ian P J Alwayn,Aad P van den Berg,Maureen M J Guichelaar et al.
Ian P J Alwayn et al.
AASLD AST Practice Guideline on Adult Liver Transplantation: Diagnosis and management of Graft-Related complications [0.03%]
美国肝病研究学会(AASLD)成人肝脏移植相关并发症诊疗指南：移植物相关并发症的诊断与管理
Helen S Te,Vatche G Agopian,Anthony J Demetris et al.
Helen S Te et al.
Background and aim: Advances in immunosuppression and surgical techniques in liver transplantation (LT) have significantly improved patient outcomes, but donor utilization and access to LT remain a challenge. The past dec...
Evaluation of living liver donors identifying as transgender or gender diverse [0.03%]
性别多样性的活体肝脏捐献者的评估研究
Tzu-Hao Lee,Thanh Nguyen,Rita S Lee et al.
Tzu-Hao Lee et al.
Transgender and gender diverse individuals face barriers to accessing equitable healthcare. As the liver transplant community works to expand and standardize the living donor evaluation, it is imperative that we consider the unique risk str...
HepB-CpG vaccination: An alternate strategy to life long antiviral therapy in patients transplanted for chronic Hepatitis B [0.03%]
乙肝免疫球蛋白 CpG 治疗：一种替代慢性乙型肝炎移植患者的终身抗病毒治疗的策略
Luis Garrido-Trevino,Stevan A Gonzalez,Giovanna Saracino et al.
Luis Garrido-Trevino et al.
Nucleoside analogue (NA) prophylaxis is given indefinitely after liver transplantation for chronic hepatitis B (CHB). We evaluated if antiviral therapy can be discontinued after vaccination with the immune adjuvanted HepB-CpG vaccine. ...